Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells by Bian, Yiying et al.
RESEARCH Open Access
Titanium dioxide nanoparticles enhance
thrombosis through triggering the
phosphatidylserine exposure and
procoagulant activation of red blood cells
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Abstract
Background: Expanding biomedical application of anatase titanium dioxide (TiO2) nanoparticles (NPs) is raising the
public concern on its potential health hazards. Here, we demonstrated that TiO2 NPs can increase
phosphatidylserine (PS) exposure and procoagulant activity of red blood cells (RBCs), which may contribute to
thrombosis.
Results: We conducted in vitro studies using RBCs freshly isolated from healthy male volunteers. TiO2 NPs exposure
(≦ 25 μg/mL) induced PS exposure and microvesicles (MV) generation accompanied by morphological changes of
RBCs. While ROS generation was not observed following the exposure to TiO2 NPs, intracellular calcium increased
and caspase-3 was activated, which up-regulated scramblase activity, leading to PS exposure. RBCs exposed to TiO2
NPs could increase procoagulant activity as measured by accelerated thrombin generation, and enhancement of
RBC-endothelial cells adhesion and RBC-RBC aggregation. Confirming the procoagulant activation of RBC in vitro,
exposure to TiO2 NPs (2 mg/kg intravenously injection) in rats increased thrombus formation in the venous
thrombosis model.
Conclusion: Collectively, these results suggest that anatase TiO2 NPs may harbor prothrombotic risks by promoting
the procoagulant activity of RBCs, which needs attention for its biomedical application.
Keywords: Titanium dioxide nanoparticles (TiO2 NPs), Phosphatidylserine (PS) exposure, Procoagulant activity,
Thrombosis, Red blood cells (RBCs)
Background
In addition to the wide use in sunscreens, titanium diox-
ide nanoparticles (TiO2 NPs) are receiving an increasing
attention for biomedical applications like cell imaging,
biological analysis, drug delivery and photodynamic ther-
apy owing to their excellent and unique photocatalytic
properties, and good biocompatibility [1–5]. Due to their
wide and heavy uses in human life, concern of health
hazard of TiO2 NPs is escalating and many researches
have illuminated that TiO2 NPs can induce various
pathological alterations in liver, spleen, kidneys and
brain [6]. Meanwhile, the toxicity of TiO2 NPs on blood
cells, the primary target cells of intravenously given sub-
stances, remains relatively unillustrated.
Indeed, previous studies demonstrated that some
nanoparticles can inflict cytotoxicity and genotoxicity on
lymphocyte cells [7, 8] and activate platelets, resulting in
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thrombosis [9, 10], reflecting that blood cells can be an
important target of toxicity for nanoparticles. RBCs are
also reported as a target of nanoparticles but the effects
are mainly limited to hemolysis, morphological alter-
ations or RBC aggregation [11–13]. Recently, an active
role of RBCs in the development of thrombotic diseases
has been demonstrated. Participating in thrombosis,
RBCs accelerate the cascade of coagulation and the for-
mation of blood clotting through externalization of
phosphatidylserine (PS) on the outer membrane provid-
ing a procoagulant sites and faciliating thrombin gener-
ation [14]. This process is called as the procoagulant
activity of RBCs, which is triggered by the perturbation
of membrane phospholipid translocases; scramblase and
flippase. Perturbation of membrane phospholipid trans-
locases are caused by upstream events of intracelluar
calcium increase, caspase activation, ROS production as
well as ATP- and thiol-depletion [15–21].
Our previous study firstly demonstrated that the pro-
coagulant activity of RBCs can be induced by silver
nanoparticles, enhancing thrombosis [22], reflecting the
role of RBCs in prothrombotic effects of nanoparticles.
Previous studies showed that TiO2 NPs can induce
hemolysis, morphological observation and a possible
interaction with RBCs via penetration [7, 23, 24], imply-
ing their potental effects on RBCs with respect to pro-
coagulant activity and thrombosis [23]. However,
previous studies have not further extended into the in-
vestigation of the possible effects of TiO2 NPs on the de-
velopment of procoagulant activity of RBCs and
thrombosis.
Here, we examined whether TiO2 NPs can affect PS
exposure and procoagulant activity of RBCs. In addition,
we clarified the underlying mechanism and investigated
the biological significances by evaluating the procoagu-
lant activity of RBCs, RBC adhesion to endothelial cells
and RBC aggregates. Importanly, the signficance of these
findings with respect to human thrombosis were further
substantiated by in vivo thrombosis using a rat venous
thrombosis model.
Results
Characterization of TiO2 NPs and TEM analysis of TiO2
NPs-exposed RBCs
The size distribution of TiO2 NPs was characterized
with scanning electron microscopy (SEM) and dynamic
light scattering (DLS). SEM observation showed that the
majority of TiO2 NPs was at the size ranges of 20 to 45
nm with the average size of 33.2 nm as calculated with
sampled one hundred particles (Fig. 1a). DLS data
showed the peak and average size by intensity in Ringer’s
solution (with 10% FBS) was 68.1 nm and 72.32 nm, re-
spectively, and in saline (with 10% FBS), was 122.4 nm
and 120.4 nm, respectively (Fig. 1b). In addition, the zeta
potential of TiO2 NPs was − 8.70 mV in Ringer’s solu-
tion and - 10.58 mV in saline (pH 7.4). The physiochem-
ical properties of TiO2 NPs were summarized in
Supplemental Table S1. Next, we could also observe that
TiO2 NPs penetrates through RBCs membranes and
enter into RBCs using transmission electron microscopy
(TEM) (Fig. 1c), which matched well the previous find-
ings provided by Li, et al., and Rothen-Rutishauser,
et al., [23, 24], indicating that TiO2 NPs exposure may
produce significant biological or toxic effects on RBCs.
Effects of TiO2 NPs on human isolated RBCs in vitro
Firstly, we determined the hemolytic reactions of TiO2
NPs on human isolated RBCs and found that 50 μg/mL
of TiO2 NPs caused a significant lysis while 0 ~ 25 μg/
mL did not, where we continued our investigation in the
following study (Fig. 2a). PS exposure and MV gener-
ation, key indicators of procoagulant activity of RBCs
participating in thrombosis, were examined using flow
cytometry [25]. Figure 2b showed that 10 to 25 μg/mL of
TiO2 NPs treatment for 24 h significantly elicited PS ex-
posure. The generation of PS-bearing MV (Fig. 2c) from
TiO2 NPs-treated RBCs also increased in a
concentration-dependent fashion. SEM observation
showed the appearance of spiny cells, called echinocytes,
in TiO2 NPs-treated groups (Fig. 2d). These findings re-
flect a well-known relationship between loss of phospho-
lipid asymmetry and morphological changes [26]. Plasma
coagulation, one of key events contributing to throm-
bosis, was estimated by measuring the prothrombin time
(PT) and the activated partial thromboplastin time
(aPTT), but no effects were induced by TiO2 NPs up to
a level of 10 folds more than that exposed to RBCs (Fig.
2e), indicating the specificity in the effects of TiO2 NPs
to RBCs. Indeed, compared to anatase TiO2 NPs, we
futher determined hemolysis and PS exposure of rutile
type and anatase/rutile mixture (Supplemental Figure 1),
showing the toxicity was mixture > anatase > rutile.
Effects of TiO2 NPs on phospholipid translocase,
intracellular calcium level ([Ca2+]i), and caspase activity in
RBCs
PS externalization is resulting from the disruption of
phospholipid asymmetry, which is controlled by a bal-
ance of phospholipid translocases activity; scramblase
and flippase [19]. After 24 h incubation with TiO2 NPs,
scramblase activity was significantly upregulated in a
concentration-dependent manner as evidenced by in-
creased C6-NBD-PC translocation (Fig. 3a, left). On the
contrary, TiO2 NPs exposure did not affect flippase ac-
tivity as examined by absence of embedded C6-NBD-PS
translocation (Fig. 3a, right), reflecting loss of phospho-
lipid asymmetry leading to PS exposure induced by TiO2
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was mainly attributable to the increased scramblase
activity.
Scramblase activity was known to be increased by ROS
[27, 28], intracellular calcium elevation [17] [29], and
caspase-3 activation [30]. Compared to the positive con-
trol (Pb-treated RBCs) and negative control, no ROS gen-
eration was observed in RBCs following the treatment of
TiO2 NPs (Fig. 3b). On the contrary, 25 μg/mL of TiO2
NPs resulted in increased [Ca2+]i in RBCs (Fig. 3c). As well
as increased [Ca2+]i, caspase-3 was significantly activated
by TiO2 NPs exposure (Fig. 3d). The roles of increased
[Ca2+]i and activated caspase 3 in TiO2 NP-induced PS ex-
posure in RBCs were further confirmed through pretreat-
ment of their inhibitors, EGTA and Z-VAD-FMK, which
succeeded to attenuate the PS exposure induced by TiO2
NPs treatment (Fig. 3e).
Procoagulant activity of TiO2 NPs-exposed RBCs
Procoagulant activity of RBCs results in accelerated
thrombin generation, a key step for blood coagulation
Fig. 1 Characterization of TiO2 NPs and transmission electron microscope (TEM) observation of cellular uptake. (a) The size distribution histogram
generated using SEM images showed TiO2 NPs of size between 15 and 65 nm with an average of 33.2 nm. Value are calculated from randomly
measuring more than 100 particles of TiO2 NPs observed by SEM. (b) Particle size distribution of TiO2 NPs in Ringer’s solution used in vitro system
and in saline used for intravenous injection showed particles of diameter with a peak of distribution at 68.1 nm and 122.4 nm, respectively (with
10% FBS in it). The results also indicated the presence of TiO2 NPs agglomerates both in Ringer’s solution and in saline. (c) Control (distilled
water) and TiO2 NPs-treated RBCs were observed using TEM after 24 h treatment. The white arrowheads indicated TiO2 NPs might go through
RBCs membranes and uptake by RBCs. Black scale bar: 2 μM. * represents significant differences from control group (p < 0.05)
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cascade, and the adhesion of RBCs to vascular wall,
which could ultimately promote thrombosis [31]. Firstly,
prothrombinase assay was performed to detect thrombin
generated by TiO2 NPs-exposed RBCs. As a result, a
concentration-dependent increase in thrombin gener-
ation was induced by TiO2 NPs as shown in Fig. 4a. It
was well-matched with PS exposure and MV generation
shown in Fig. 2b and c. Also, TiO2 NPs-exposed RBCs
were more-adhesive to ECs with a concentration-
dependent trend as observed by fluorescence microscopy
shown in Fig. 4b. Of note, some red aggregates also ap-
peared in TiO2 NPs-treated groups, suggestive of RBCs
Fig. 2 Effects of TiO2 NPs on human RBCs and plasma coagulation. (a) After isolated human RBCs were treated with various concentrations (0, 5,
10, 25 and 50 μg/mL) of TiO2 NPs at 37 °C for 24 h, the hemolytic activity was measured at 540 nm. (b-d) Isolated human RBCs were treated with
various concentrations (0, 5, 10 and 25 μg/mL) of TiO2 NPs at 37 °C for 24 h. And then, (b) PS exposure and (c) MV generation were
concentration-dependent promoted, which was determined using flow cytometry. (d) Morphological alteration was observed using SEM and
echinocytes were concentration-dependently shown in TiO2 NPs-treated RBCs. (e) Plasma coagulation was evaluated by prothrombin time (PT)
and activated partial thromboplastin time (aPTT) after human plasma was incubated with 0, 25, 100 and 250 μg/mL TiO2 NPs. Thrombin (1 U/mL)
was used as positive control. Scale bar: 5 μm. Values are mean ± S.E. of 3–5 independent experiments, * represents significant differences from the
control group (p < 0.05)
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aggregation after TiO2 NPs exposure. Indeed, TiO2 NPs-
exposed RBCs became more prone to aggregate in a
concentration-dependent fashion (Fig. 4c).
Prothrombotic effects of TiO2 NPs exposure in vivo
Prior to in vivo assessment of TiO2 NPs in rats, a bridge
study was performed using freshly isolated rats RBCs to
confirm the procoagulant effects of TiO2 NPs on rat
RBCs. Consistently with human RBCs, rat RBCs exposed
to TiO2 NPs showed a concentration-dependent increase
in PS exposure and thrombin generation (Fig. 5a)
(Scheme 1). Next we examined whether TiO2 NPs ex-
posure could elicit thrombosis using venous thrombosis
rat model 1 h after TiO2 NPs were intravenously injected
(0, 2, 10, 25 mg/kg) to rats. On average, rats have around
64ml of blood per kg of bodyweight [32]. And when we
injected 2 mg/kg of TiO2 NPs, there will be around
30 μg/mL in rat blood, which matched well with in vitro
concentrations exposed to isolated blood. As a result,
thrombus formation was significantly increased by TiO2
NPs in a dose-related fashion (Fig. 5b), confirming the
thrombotic risks of TiO2 NPs.
Discussion
In this study, we demonstrated that titanium dioxide
nanoparticles (TiO2 NPs) could initiate phosphatidylser-
ine (PS) exposure and promote procoagulant activity in
isolated human red blood cells (RBCs) and rat RBCs.
Here, intracellular calcium increase and caspase 3 activ-
ity up-regulated scramblase activity leading to loss of
phospholipid asymmetry and PS exposure in TiO2 NPs-
treated RBCs. Furthermore, TiO2 NPs led to accelerated
thrombin generation, RBC-EC adhesion as well as RBC
aggregation, and more importantly, could increase
thrombus formation in rats in vivo supporting the rele-
vance of our findings to real in vivo states.
Fig. 3 Intracellular events underlying PS exposure in RBCs induced by TiO2 NPs. Isolated human RBCs were treated with various concentrations (0,
5, 10 and 25 μg/mL) of TiO2 NPs at 37 °C for 24 h. Next, phospholipid translocation was shown by (a) concentration-dependently increased
scramblase activity and (b) no changes of flippase activity. (b) ROS generation was determined through preloading 5 μM CM-H2DCF-DA for 30
min, and beta-lapachone was used as positive control. (c) Intracellular calcium, [Ca2+]i, was examined by preloading 3 μM fluo-4 AM for 1 h. (d)
Caspase 3 activity was increased as measured shown in Method. (e) Inhibition of PS exposure was performed by preloading various inhibitors, a
calcium chelating agent (5 mM EGTA) or caspase inhibitors (Z-VAD-FMK and Q-VD-Oph) for 3 h prior to exposure to TiO2 NPs for 24 h. Values are
mean ± S.E. of 3–5 independent experiments, * represents significant differences from the control group (p < 0.05)
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Previous studies showed that TiO2 NPs can induce
toxicity in various cells and tissues in vitro, such as
lymphocytes, platelets and liver tissues, but their
pathophysiological implications remained unexplored
[6, 7, 10, 33, 34]. In RBCs, hemolysis is repeatedly
observed as TiO2 NP-induced toxicity in several stud-
ies [7, 24, 35], but its pathophysiological significance
is poorly understood. Recently, Li et al. have observed
that TiO2 NPs adhere to RBC membranes and induce
the morphological alterations [24]. In this study, we
demonstrated that the TiO2 NPs can induce pro-
coagulant activation of RBCs both in vitro and
in vivo systems. We also elucidated its underlying
mechanisms and explored its further biological signifi-
cance in terms of thrombosis, providing with a com-
prehensive and convincing evidence on the
prothrombotic effects of TiO2 via the procoagulant
activity of RBCs.
TiO2 NPs are applied via intravenous administration
for their medical uses [36], raising the necessity of the
careful and rigorous safety assessment of TiO2 applica-
tion in vivo. An earlier study investigated TiO2 toxicity
in mice using an extremely high dosage (0, 140, 300,
645, or 1387 mg/kg), found diverse degrees of dysfunc-
tion in the brain, lung, spleen, liver and kidneys [37].
Another study demonstrated that i.v. injection of 5 mg/
kg of TiO2 to rats were without detectable toxicity, and
suggested a safe level of TiO2 up to 5 mg/kg [38]. But
these studies appear to focus the general toxicology,
leaving subtle pathophysiological effects unaddressed.
Our study showed that TiO2-injection at 2 mg/kg i.v can
provoke thrombosis, suggesting that careful attention
Fig. 4 Biological functions of human RBCs after TiO2 NPs treatments. After isolated human RBCs were treated with various concentrations (0, 5, 10
and 25 μg/mL) of TiO2 NPs for 24 h at 37 °C, (a) procoagulant activity was shown by a concentration-dependent trend of thrombin generation
using prothrombinase assay and (b) enhanced adherent RBCs to HUVECs was detected by fluorescence microscope as described in Methods.
Endothelial cells (green fluorescence); RBCs (red fluorescence). Required further confirmation in the following study (white arrow). (b, right) The
increased intensity shown as a bar graph was the fluorescence of red color, reflecting the relatively adherent RBCs to HUVECs. (c) RBC
aggregation (white arrows) was initiated by 24 h treatment with TiO2 NPs as observed by fluorescence microscopy. Scale bar: 50 μm. Values are
mean ± S.E. of 4 independent experiments, * represents significant differences from the control group (p < 0.05)
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shall be paid for pathophysiological effects of TiO2 NPs
as well to ensure the safety.
In addition, bio-distribution after i.v. injections of
TiO2 NPs in rats investigated in several studies revealed
that a majority of TiO2 NPs distributes in blood followed
by spleen, liver and lung [38–40]. A recent study showed
that after i.v. administration of 0.95 mg/kg TiO2 NPs in
rats, the blood level of 420 ng/mL was observed at 5
min, which is similar to the range employed in our stud-
ies in vitro and in vivo. Moreover, the half-life of TiO2
NPs was determined to be very long ranging up to 12.56
days in rat after giving i.v injection [39], suggesting that
stronger prothrombotic effects of TiO2 NPs could be an-
ticipated, although further studies are necessary to con-
firm it.
Oxidative stress accompanied by decreased glutathione
and overproduced ROS has been frequently involved in
the toxicity of TiO2 NPs exposure [41, 42]. In contrast,
we found no obvious production of ROS in TiO2 NPs-
treated RBCs at any concentrations, which is in line with
a previous finding that intracellular glutathione levels in
blood, lung and liver cells were not affected by TiO2
NPs [43]. Instead, we newly found that intracellular cal-
cium and caspase-3 activation are elicited after TiO2
NPs exposure, revealing new molecular targets for the
toxicity of TiO2 NPs. We suggest that studies are neces-
sary to identify the role of intracellular calcium increase
and caspase-3 activation in other pathological effects of
TiO2 NPs in the near future.
Various TiO2 NPs possess distinct physicochemical
properties, such as particle sizes, crystalline forms (ana-
tase or rutile phase), surface modification (surface charge
and coating), and protein corona formation, each of
which would be expected to substantially affect their
biological properties. It is well established that the ana-
tase form of TiO2 is more bioactive than rutile type
which, together with smaller size, can result in greater
toxicity [6, 44]. Also, the surface functionalization of
NPs with negatively charged groups could alleviate the
erythrocyte aggregating effects of these NPs [45], which
could be attributable to the formation of a complex sys-
tem on the NP surface induced by surface modification.
Exemplifying this, a previous study showed that BSA-
coated gold NPs induce significantly lower hemolysis
[46]. NP-protein corona complex formation could also
affect the biological properties of NPs [47]. A previous
study demonstrated that the formation of plasma protein
corona on NP surface protects RBCs from both hydro-
philic and hydrophobic NP-mediated hemolysis [48].
Against this backdrop, we believe that it would be inter-
esting to examine the effects of various TiO2 NPs for
thrombotic risk mediated by RBCs in the future.
Conclusion
Our study revealed the prothrombotic effect of TiO2
NPs via the procoagulant activity of RBCs, which we
demonstrated with in vitro and in vivo assessments. We
could also propose the mechanism underlying by
Fig. 5 Thrombotic effects of TiO2 NPs exposure after intravenously injection to rat. (a) Blood was freshly collected from 8-week-old SD rats, and
isolated rat RBCs were further incubated with various concentrations (0, 5, 10 and 25 μg/mL) of TiO2 NPs. (a, left) PS exposure as well as (a, right)
thrombin generation were evaluated. (b) In a venous animal model, various doses of TiO2 NPs was intravenously injected to rats, and 1 h later,
thrombus formation was assessed. Values are mean ± S.E. of 4–5 independent experiments, * represents significant differences from the control
group (p < 0.05)
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showing that TiO2 NPs-induced PS exposure in isolated
human RBCs was related to increased [Ca2+]i level and
caspase 3 activity but independent of ROS generation.
Most importantly, we demonstrated the in vivo rele-
vance of our findings through showing that TiO2 NPs
exposure can increase thrombosis in rat venous throm-
bosis model in vivo, reflecting the need of an attention
during medical use of TiO2 NPs.
Methods
Materials
The following chemicals were purchased from Sigma
Chemical Co. (St. Louis, MO): TiO2 (titanium dioxide, an-
atase, nanopowder, < 25 nm particle size, 99.7% trace
metals basis.), L-ascorbic acid, N-acetylcysteine, glutalde-
hyde solution and osmium tetroxide, CaCl2, glucose, eth-
ylenediaminetetraacetic acid (EDTA), bovine serum
albumin (BSA), N-[2Hydroxyethyl]piperazine- N´-[2-etha-
nesulfonic acid] (HEPES), sodium dodecyl sulfate and
purified human thrombin. Phycoerythrin-labeled mono-
clonal mouse anti-human CD235a and fluorescein-
isothiocyanate (FITC)-labeled annexin V (annexin V-
FITC) were from BD Pharmingen (San Diego, CA). Fluo-4
acetoxymethyl ester (fluo-4 AM) and the chloromethyl de-
rivative of 2′, 7′-dichlorodihydrofluorescein diacetate





were from Avanti Polar Lipids (Alabaster, AL). Caspase 3
detection kit (FITC-DEVE-FMK) was purchased from
Calbiochem (San Diego, CA). Caspase-3 inhibitor II and
Q-VD-OPh were obtained from Merck Millipore. Purified
human prothrombin, factor Xa and factor Va were from
Hematologic Technologies, Inc. (Essex Junction, VT), and
S2238 was from Chromogenix (Milano, Italy). Human
umbilical vein endothelial cells (HUVECs) and the endo-
thelial cell growth media (EGM) kit were purchased from
Lonza. Calcein-green AM was from Invitrogen (Carlsbad,
CA). Human recombinant tissue factor (Recombiplastin)
was obtained from Instrumentation Laboratory (Lexing-
ton, MA) and thromboplastin (Simplastin Excel) was from
Biomerieux (Durham, NC).
Preparation of RBCs
With the approval from the Ethics Committee of Health
Service Center at Seoul National University, we collected
blood from healthy volunteers. As gender, age and dis-
eases are all risk factors of thrombosis, we only used
healthy male donors ranging from 20 to 30 years old to
simplify our study design. Human blood was collected
using a vacutainer with acid citrate dextrose (ACD) and
a 21 gauge needle (Becton Dickinson, U.S.A.) on the day
of each experiments. Platelet rich plasma and buffy coat
were removed after centrifugation at 200 g for 15 min.
Packed RBCs were washed twice with phosphate buff-
ered saline (PBS: 1.06 mM KH2PO4, 154 mM NaCl and
2.96 mM Na2HPO4 at pH 7.4) and once with Ringer’s so-
lution (125 mM NaCl, 5 mM KCl, 1 mM MgSO4, 32 mM
HEPES, 5 mM glucose, pH 7.4). Washed RBCs were re-
suspended in Ringer’s solution to a final cell concentra-
tion of 5 × 107 cells/mL with 1mM CaCl2 before use.
Characterization of TiO2 NPs
TiO2 NPs were purchased from Sigma Aldrich (refer-
ence 637,254). They are nano powder, < 25 nm particle
size and 99.7% trace metals basis. All heavy metal im-
purities detected in the sample were equal to/under 65
ppm via XRF. The density is 3.9 g/ml (relative density)
and 0.04–0.06 g/mL (bulk density). Fusion temperature
was determined as 1825 °C and specific surface area as
44–55m2/g via BET. It is not surface treated. Sigma did
not test the solubility or dissolution of this product.
However, these products are insoluble in water, HCl,
HNO3 and dilute H2SO4. It is soluble in hot concen-
trated H2SO4 and hydrofluoric acid (supplier data).
Preparation of TiO2 NPs suspension was carried out
Scheme 1 Venous Thrombosis induced by TiO2 NPs via RBCs.
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according to the methods previously described. TiO2
NPs were dispersed in distilled water as 100 X stock so-
lution (1–25mg/mL) and sonicated with a probe type
sonicator with a maximum output power, 200W (Bran-
son Sonifier, Danbury, CT) for 30 s to prevent particles
self-assembly (agglomeration) prior to each experiment.
For the characterization of TiO2 NPs, TiO2 NPs was
dried and was observed with scanning electron micro-
scope (SEM) (ZEISS, MERLIN Compact) to examine the
size distribution. A detailed statistical analysis of TiO2
NPs was performed by randomly measuring 100 nano-
particles and the procedure was operated by manually
outlining the particles from several images taken by
SEM. The hydrodynamic diameter and the zeta potential
of the nanoparticles were measured by dynamic light
scattering (DLS-7000, Otsuka Electronics, Co., Osaka,
Japan) and electrophoretic light scattering (ELSZ-1000
Photal; Otsuka Electronics,Co., Osaka, Japan),
respectively.
Cellular uptake of TiO2 NPs by RBCs was observed
using TEM after the following procedures. After 24 h in-
cubation of isolated RBCs with distilled water (as con-
trol) and 25 μg/mL of TiO2 NPs dispersed as a colloidal
suspension in distilled water, 2% glutaraldehyde solution
was used for cell fixation in the refrigerator for 1 h and
1% osmium tetroxide was used for post-fixation for 2 h.
After en-bloc staining with 0.5% uranyl acetate for 30
min, serially dehydration was done with 30, 50, 70, 80,
90% (1 time) and 100% ethanol (3 times). Next, transi-
tion and infiltration was gradually done with propylene
oxide (10 min, 2 times), once with propylene oxide and
spurr’s resin (1,1) for 2 h, and spurr’s resin in the desic-
cator overnight. On the next day, infiltration was com-
pleted with newly spurr’s resin for 2 h in the desiccator,
then samples were kept in the 70 °C oven overnight for
polymerization. Finally, samples were observed under
TEM (JEOL, JEM 1010).
Evaluation of hemolysis
After incubation with TiO2 NPs, samples were centri-
fuged (10,000 g for 1 min) and the extent of hemolysis
was determined spectrophotometrically at 540 nm.
Ringer’s solution and RBCs lysed with triton X-100 were
used as blank and 100% hemolysis, respectively.
Flow cytometric analysis
Annexin V-FITC and anti-glycophorin A-PE were used
for PS detection and RBC identification, respectively.
Negative controls for annexin V binding were in the
presence of 2.5 mM EDTA instead of 2.5 mM CaCl2.
Flow cytometer FACS Calibur (Becton Dickinson,
U.S.A.) equipped with an argon-ion laser emitting at
488 nm was applied for sample analysis. Data from 5000
events were collected and analyzed using Cell Quest Pro
software. PS were identified by forward scatter charac-
teristics after calibration by 1% standard beads. Both PS
exposure in RBC area and MV area could be analyzed.
For determination of phospholipid translocation,
0.5 μM C6-NBD-PC (for scramblase activity) and C6-
NBD-PS (for flippase activity) were added to TiO2 NPs-
activated RBCs, respectively, for various durations (0, 20,
40 and 60min) at 37 °C. The amount of internalized
probe was determined by comparing the fluorescence in-
tensity associated with the cells before (without 1% bo-
vine serum albumin) and after (with 1% bovine serum
albumin) back-extraction on ice for 10 min.
With flow cytometry, ROS generation and intracellular
calcium ([Ca2+]i) were performed by determination of
the fluorescence of intracellular DCF with pre-loading
5 μM CM-H2DCF-DA with RBCs (30 min, 60 rpm, 37 °C
water bath, dark) and the fluorescence of fluo-4 with
pre-loading 3 μM Fluo-4 AM with RBCs (1 h, 60 rpm,
37 °C water bath, dark) before TiO2 NPs treatments.
As well, caspase-3 activity was measured by post-
adding 1 μL FITC-DEVD-FMK (a caspase-3 inhibitor
conjugated to FITC as the fluorescent in situ marker) to
300 μL TiO2 NPs exposed-RBCs suspension (37 °C,
1000 rpm, dark). Re-suspended cells after centrifugation
(1000 g for 5 min) and twice washing was detected using
flow cytometry. Data from 5000 events were collected
and analyzed using Cell Quest Pro software (Becton
Dickinson).
Morphological alteration observation using scanning
electron microscopy (SEM)
After incubation with TiO2 NPs, RBCs were pre-fixed
with 2% glutaraldehyde solution for 1 h at 4 °C and post-
fixed with 1% osmium tetroxide for 30 min at room
temperature in the hood. Then, samples were dehy-
drated serially with 50, 70, 80, 90, and 100% ethanol.
After drying and coating with gold, the morphological
alteration were observed on a SEM.
Experiments with plasma
Platelet-poor plasma (PPP) was obtained from the pre-
cipitated fraction of PRP by centrifugation for 20 min at
2000 g. In PPP, PT and aPTT were measured in BBL
Fibrometer (Becton Dickinson, Cockeysville, Maryland),
based upon the procedures in PT and aPTT reagent kit,
respectively.
Prothrombinase assay
After incubation with TiO2 NPs for 24 h, samples were
incubated with 5 nM factor Xa and 10 nM factor Va in
Tyrode buffer (134 mM NaCl, 10 mM HEPES, 5 mM
glucose, 2.9 mM KCl, 1 mM MgCl2, 12 mM NaHCO3,
0.34 mM Na2HPO4, 0.3% BSA, and 2mM CaCl2 at pH
7.4) for 3 min at 37 °C. Thrombin formation was
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initiated by adding 2 μM prothrombin. Exactly 3 min
after adding prothrombin, an aliquot of the suspension
was transferred to a tube containing stop buffer (50 mM
Tris-HCl, 120mM NaCl, and 2mM EDTA at pH 7.9).
Thrombin activity was determined using the chromo-
genic substrate S2238 (chromogenic substrate for
thrombin; Chromogenix, Milano, Italy). We calculated
the rate of thrombin generation from the change in ab-
sorbance at 405 nm using a calibration curve generated
with active-site–titrated thrombin.
Observation under fluorescence microscope
Endothelial cells (2 × 104 cells) were seeded in a 4-well-
chamber for 2 days and stained with calcein green for
20 min. TiO2 NPs-treated RBCs were washed once and
resuspended in EBM-2 to a final cell concentration of
5 × 107 cells/mL. After HUVECs were washed twice with
EBM-2, TiO2 NPs-exposed RBCs were layered onto con-
fluent HUVEC monolayer and incubated for 60 min at
37 °C. After the incubation, the chambers were rinsed
once with EBM-2 to remove non-adherent RBCs, and
glycophorin A-PE were added for staining RBCs. Ad-
hered RBCs to HUVECs were observed using fluorescent
microscopy.
Moreover, aggregation of chemical-exposed RBCs was
observed using fluorescence microscopy after adding gly-
cophorin A-PE.
In vivo assessment
Sprgue-Dawley (SD) rats (male, 300–400 g) were anes-
thetized with urethane (1.25 g/kg, i.p.). Blood (3.8% so-
dium citrate) was collected from abdominal aorta and
RBCs were isolated as human RBCs preparation. Isolated
rat RBCs were further incubated with TiO2 NPs for 24 h,
then PS exposure and procoagulant activity were deter-
mined mentioned above.
In a thrombosis animal model, we surgically opened
the abdomen and carefully dissected to expose the vena
cava. A 16mm apart around the vena cava was prepared
with two pieces of loose cotton threads each side and we
ligated all side branches tightly with cotton threads.
Here, the NPs were suspended in saline (0.9% NaCl) for
intravenous injection. 1 h after intravenously injecting
TiO2 NPs (0, 2, 10 or 25 mg/kg) into a left femoral vein,
we infused 500-fold diluted thromboplastin for 1 min to
induce thrombus formation. Stasis was initiated by tight-
ening the two threads, first the proximal and the distal
thereafter. The abdominal cavity was provisionally
closed, and blood stasis was maintained for 15 min. After
reopening the abdomen, the ligated venous segment was
excised and opened longitudinally to remove the
thrombus. The isolated thrombus was blotted of excess
blood and immediately weighed.
Statistical analysis
The means and standard errors of means were calcu-
lated for all treatment groups. The data were subjected
to two-way analysis of variance followed by Duncan’s
multiple range test or student t test to determine which
means were significantly different from the control. In
all cases, a p value of < .05 was used to determine sig-
nificant differences.
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The online version contains supplementary material available at https://doi.
org/10.1186/s12989-021-00422-1.
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anatase/rutile mixture TiO2 NPs on hemoytic response and PS
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of human isolated red blood cells was determined after 24 h exposure to
50 μg/mL of each types of TiO2 NPs including anatase, rutile (Sigma
637,262, nanopowder, < 100 nm particle size via BET, 99.5% trace metals
basis) and anatase/rutile mixture (Sigma 634,662, < 100 nm particle size
via BET, 99.5% trace metals basis). Values are mean ± S.E. of 3–5
independent experiments, * represents significant differences from the
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